Results 71 to 80 of about 4,590 (196)

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2012
The three currently marketed long-acting insulin analogs, glargine, detemir and insulin lispro protamine suspension (ILPS), represent the most significant advances in basal insulin supplementation since the 1940s and 1950s and the introduction of the ...
Dario Giugliano, Katherine Esposito
doaj   +1 more source

Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A 1 chieve study

open access: yesIndian Journal of Endocrinology and Metabolism, 2014
Aim: To determine the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) therapy in the Indian patients with type 2 diabetes previously on basal or basal-bolus insulin therapies.
Arpandev Bhattacharyya   +3 more
doaj   +1 more source

Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

open access: yesEndocrinology, Diabetes &Metabolism, Volume 8, Issue 3, May 2025.
Once‐daily insulin provides superior HbA1c reduction compared to once‐weekly insulin in type 1 diabetes, while fasting blood glucose levels remain comparable. Although once‐weekly insulin may improve adherence, it is associated with higher rates of injection site reactions and adverse events, requiring careful consideration of patient‐specific factors ...
Obieda Altobaishat   +7 more
wiley   +1 more source

A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine

open access: yesIndian Journal of Pharmacology, 2015
Insulin is an important agent for the treatment of diabetes mellitus (DM). Allergic reactions to insulin therapy, although rare, have been evident since animal insulin became available for the treatment of DM in 1922. Hypersensitivity to insulin has considerably been reduced with the introduction of human insulin produced by recombinant ...
Sarayu A. Pai   +5 more
openaire   +4 more sources

Clinically meaningful improvements in treatment satisfaction in insulin‐naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real‐world ATOS study

open access: yes
Diabetes, Obesity and Metabolism, EarlyView.
Frank Snoek   +11 more
wiley   +1 more source

Increased Expression of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Brain of Chronic Diabetic Rats

open access: yesSynapse, Volume 79, Issue 3, May 2025.
Synaptic vesicle glycoprotein 2A (SV2A) is a key marker of synaptic density and the target of UCB‐J PET radioligands. In rats with chronic hyperglycemia (glucose >13.8 mmol/L), [3H]UCB‐J binding and SV2A levels were significantly elevated in the cortex and hippocampus, alongside increased glutamate release, despite unchanged levels of other presynaptic
Burcu Azak Pazarlar   +3 more
wiley   +1 more source

Modeling and Optimization of Insulin Injection for Type-1 Diabetes Mellitus Management [PDF]

open access: yes
Diabetes mellitus is a global health crisis characterized by poor blood sugar regulation, impacting millions of people worldwide and leading to severe complications and mortality. Although Type 1 Diabetes Mellitus (T1DM) has a lower number of cases compared to other forms of diabetes, it is often diagnosed at a young age and requires lifelong exogenous
arxiv   +1 more source

Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type‐2 diabetes and chronic kidney disease: DPV registry study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2485-2494, May 2025.
Abstract Aims Managing type‐2 diabetes (T2D) in chronic kidney disease (CKD) patients requires consideration of kidney function, and many drugs have not been investigated thoroughly. Clinical studies have demonstrated Glargine U300 (Gla‐300) supports achievement of adequate glycemic control at low hypoglycemia risk.
Anjaly Vijayan   +9 more
wiley   +1 more source

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia

open access: yesClinicoEconomics and Outcomes Research, 2020
Asrul Akmal Shafie,1 Chin Hui Ng2 1Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Penang, Malaysia; 2Pharmacy Department, Hospital Raja Permaisuri Bainun, Ipoh 30450, Perak, MalaysiaCorrespondence: Asrul Akmal ...
Shafie AA, Ng CH
doaj  

The insulin superfamily of growth-promoting proteins [PDF]

open access: yesarXiv, 2007
Recently, structural analysis of the human transferrin and growth hormone (GH) amino acid sequences has unravelled that they harbor a motif identical to a pattern found in viral oncoproteins known to bind the primarily nuclear tumor suppressor retinoblastoma protein (RB).
arxiv  

Home - About - Disclaimer - Privacy